Can Honey Really Outperform Modern Antibiotics?

In this episode, we dive deep into the hardcore clinical science behind why medical-grade Manuka honey is being used in hospitals to treat chronic wounds that traditional antibiotics simply cannot fix. Join Jordan, a commercial beekeeper, and Quinn, an expert in Apiology and wound microbiology, as they bridge the gap between the hive and the hospital.

The Biofilm Problem

Traditional treatments often fail because bacteria in chronic wounds don't just float around; they build 3D protective fortresses called biofilms. These structures are made of an EPS matrix that makes bacteria up to 1,000 times more resistant to antibiotics. We explore the three layers of defense—physical barriers, chemical inactivation, and metabolic dormancy—that make these infections so stubborn.

The Triple Mechanism of Destruction

Learn how Manuka honey deploys a synergistic triple attack to collapse the EPS matrix and destroy pathogens like MRSA and Pseudomonas aeruginosa:

Clinical Proof & Standards

We discuss the 400mg/kg MGO threshold required for biofilm destruction and review staggering clinical data, including a 90% reduction in MRSA biofilm mass within just 48 hours. We also cover FDA-cleared products like Medihoney and how this research is being integrated into modern regulatory frameworks.

Explore the Research: For full clinical references, 510(k) clearance numbers, and a live feed of the latest PubMed studies, visit ManukaWoundScience.org.